2712343-38-7
2712343-38-7
Chemical Structure
Raltegravir-d4
- CAS No.: 2712343-38-7
- Formula:C20H17D4FN6O5
- Molecular Weight:448.44
IUPAC Name: N-(2-(4-(fluoro((phenyl-2,3-d2)methyl-d2)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide
InChIKey: CDFRHQCVICVWAL-GZCATNODSA-N
SMILES: O=C(C1=NN=C(C)O1)NC(C)(C2=NC(C(N(F)C([2H])([2H])C3=CC=CC([2H])=C3[2H])=O)=C(O)C(N2C)=O)C
Biological Activity: Raltegravir-d4 is deuterium labeled Raltegravir. Raltegravir is a potent integrase (IN) inhibitor, used to treat HIV infection.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Raltegravir-d4 | Raltegravir-d4 is deuterium labeled Raltegravir. Raltegravir is a potent integrase (IN) inhibitor, used to treat HIV infection. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Raltegravir (Standard) | ≥98% | Raltegravir (Standard) is the analytical standard of Raltegravir (HY-10353). This product is intended for research and analytical applications. Raltegravir is a potent integrase (IN) inhibitor, used to treat HIV infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Raltegravir-d6 | Raltegravir-d6 is a deuterated labeled Raltegravir. Raltegravir is a potent integrase (IN) inhibitor, used to treat HIV infection. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Raltegravir | 99.82% | Raltegravir is a potent integrase (IN) inhibitor, used to treat HIV infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
